TURKU, FINLAND — Even if electrical cardioversion of atrial fibrillation (AF) is carried out without anticoagulation within 48 hours of acute-AF onset, the first 12 hours of that period provide by far ...

March 26, 2010 (Atlanta, GA) - Patients at high risk of relapse after electrical cardioversion of atrial fibrillation (AF) are more likely to stay in sinus rhythm if they take an omega-3 ...

Pharmacological- and electrical-first cardioversion worked similarly well for treating acute atrial fibrillation (Afib) in the emergency department, according to the Canadian RAFF2 trial. The 204 ...

Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...

Endurance athletes may be at increased risk for lone atrial fibrillation. 1–5 We describe a middle-aged physician athlete with paroxysmal lone atrial fibrillation in whom cardioversion consistently ...

Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...

Cardioversion is commonly performed as part of the rhythm control strategy for symptom and quality of life improvement in symptomatic patients with atrial fibrillation (AF). Better symptom management ...

A cardioversion procedure can reset your heart to its normal rhythm. There are two types: Electrical cardioversion. Your doctor gives your heart an electrical shock through paddles or patches on your ...

A multicenter randomized controlled clinical trial confirms that both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation; however, an ...

VANCOUVER, Cardiome Pharma Corp. today announced that an independent study conducted by investigators at the University of Leipzig Heart Center,Germany, found that intravenous vernakalant facilitated ...

The RHEIA trial, which found transcatheter aortic valve replacement (TAVR) superior to surgery for women, was among the highlights of the European Society of Cardiology (ESC) congress. Also at ESC was ...